Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept
Authors
Keywords
Juvenile idiopathic arthritis, Etanercept, Pediatric rheumatology, TNF inhibitors, Biologic therapies
Journal
Pediatric Rheumatology
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-12-20
DOI
10.1186/s12969-016-0126-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)
- (2015) Jens Klotsche et al. ANNALS OF THE RHEUMATIC DISEASES
- Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
- (2015) Rebecca Davies et al. Arthritis & Rheumatology
- Female Sex and Oligoarthritis Category Are Not Risk Factors for Uveitis in Italian Children with Juvenile Idiopathic Arthritis
- (2014) S. Calandra et al. JOURNAL OF RHEUMATOLOGY
- Defining Criteria for Disease Activity States in Nonsystemic Juvenile Idiopathic Arthritis Based on a Three-Variable Juvenile Arthritis Disease Activity Score
- (2014) Alessandro Consolaro et al. ARTHRITIS CARE & RESEARCH
- Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score
- (2013) Alessandro Consolaro et al. ANNALS OF THE RHEUMATIC DISEASES
- Brief Report: Incidence of Selected Opportunistic Infections Among Children With Juvenile Idiopathic Arthritis
- (2013) Timothy Beukelman et al. ARTHRITIS AND RHEUMATISM
- Methotrexate Therapy May Prevent the Onset of Uveitis in Juvenile Idiopathic Arthritis
- (2013) Charalampia Papadopoulou et al. JOURNAL OF PEDIATRICS
- Juvenile idiopathic arthritis—are biologic agents effective for pain?
- (2013) Alessandro Consolaro et al. Nature Reviews Rheumatology
- Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders
- (2013) Grace Levy-Clarke et al. OPHTHALMOLOGY
- Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment
- (2013) Johanne Jeppesen Lomholt et al. Pediatric Rheumatology
- Juvenile idiopathic arthritis and malignancy
- (2013) N. Ruperto et al. RHEUMATOLOGY
- Improvement in Health-Related Quality of Life for Children With Juvenile Idiopathic Arthritis After Start of Treatment With Etanercept
- (2013) Jens Klotsche et al. ARTHRITIS CARE & RESEARCH
- Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score
- (2012) Alessandro Consolaro et al. ARTHRITIS AND RHEUMATISM
- Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
- (2012) Timothy Beukelman et al. ARTHRITIS AND RHEUMATISM
- Factors Associated with Achievement of Inactive Disease in Children with Juvenile Idiopathic Arthritis Treated with Etanercept
- (2012) N. SOLARI et al. JOURNAL OF RHEUMATOLOGY
- Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis
- (2011) Marieke H. Otten et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A New Approach to Clinical Care of Juvenile Idiopathic Arthritis: The Juvenile Arthritis Multidimensional Assessment Report
- (2011) GIOVANNI FILOCAMO et al. JOURNAL OF RHEUMATOLOGY
- Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept
- (2011) T. D. van DIJKEN et al. JOURNAL OF RHEUMATOLOGY
- American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
- (2011) Carol A. Wallace et al. ARTHRITIS CARE & RESEARCH
- Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis
- (2010) Edward H. Giannini et al. ARTHRITIS AND RHEUMATISM
- Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study
- (2010) J. F. Simard et al. ARTHRITIS AND RHEUMATISM
- Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the food and drug administration
- (2010) Peter Diak et al. ARTHRITIS AND RHEUMATISM
- Anti-TNF-α Treatment: A Possible Promoter in Endogenous Uveitis? Observational Report on Six Patients: Occurrence of Uveitis Following Etanercept Treatment
- (2010) Vinodh Kakkassery et al. CURRENT EYE RESEARCH
- Fatal group A Streptococcus purpura fulminans in a child receiving TNF-α blocker
- (2010) Christian Renaud et al. EUROPEAN JOURNAL OF PEDIATRICS
- Evaluation of 21-Numbered Circle and 10-Centimeter Horizontal Line Visual Analog Scales for Physician and Parent Subjective Ratings in Juvenile Idiopathic Arthritis
- (2010) G. FILOCAMO et al. JOURNAL OF RHEUMATOLOGY
- Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study
- (2010) A. Dallocchio et al. RHEUMATOLOGY
- Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients
- (2010) T. R. Southwood et al. RHEUMATOLOGY
- Report on malignancies in the German juvenile idiopathic arthritis registry
- (2010) G. Horneff et al. RHEUMATOLOGY
- Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis
- (2010) An D. Billiau et al. RHEUMATOLOGY
- Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis
- (2010) V. Papsdorf et al. RHEUMATOLOGY
- Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis
- (2009) F H M Prince et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis
- (2009) E. H. Giannini et al. ARTHRITIS AND RHEUMATISM
- Crohn’s disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature
- (2009) V. Wiegering et al. RHEUMATOLOGY INTERNATIONAL
- Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept
- (2009) M. Halbig et al. RHEUMATOLOGY INTERNATIONAL
- Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis
- (2008) P Tynjala et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
- (2008) F H M Prince et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
- (2008) G Horneff et al. ANNALS OF THE RHEUMATIC DISEASES
- Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis
- (2008) Silvia Magni-Manzoni et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
- (2008) Daniel J. Lovell et al. ARTHRITIS AND RHEUMATISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started